44 results
Page 2 of 3
8-K
rsh35d 5b2
24 Jan 22
Entry into a Material Definitive Agreement
8:00am
424B3
xm86v33bk 394ky
14 Jan 22
Prospectus supplement
5:18pm
424B5
97ns56
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
zbcbvd3 zmo0evqof
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
1ms4 0nq2o0u
22 Nov 21
Definitive proxy
4:37pm
424B5
d2ws1uvx o3q4
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
b40n97dh
14 May 21
Quarterly report
4:31pm
10-K
wo76a
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
t79jlkohax tp
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
8-K/A
EX-99.1
zve624z pg
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.2
ypk3003
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
5kki 4010148
2 Nov 20
Prospectus supplement
12:00am